{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:10:49Z","timestamp":1788459049571,"version":"build-2803163510"},"reference-count":45,"publisher":"American Society of Hematology","issue":"1","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Multiple myeloma (MM) is twice as common in Black individuals compared with in White individuals, and diabetes mellitus (DM) disproportionately affects Black patients. Although numerous studies have shown a correlation between DM and MM, this has not been studied in the context of race and in\u00a0vivo mechanisms. We conducted a retrospective clinical study of 5383 patients with MM of which 15% had DM (White, 12% and Black, 25%). Multivariable Cox models showed reduced overall survival (OS) for patients with DM (hazard ratio, 1.27; 95% confidence interval, 1.11-1.47; P\u00a0&amp;lt; .001). This appeared to be driven by a marked difference in OS between White patients with and without DM but not in Black patients. In contrast, obesity was associated with better OS in Black patients but not in White patients. To complement this analysis, we assessed MM growth in a genetically engineered immunocompromised nonobese diabetic (Rag1\u2212\/\u2212\/muscle creatinine kinase promoter expression of a human IGF1R [M] with a lysine [K] to arginine [R] point mutation) mouse model to evaluate the mechanisms linking DM and\u00a0MM. MM.1S xenografts grew in more Rag1\u2212\/\u2212\/MKR mice and grew more rapidly in the Rag1\u2212\/\u2212\/MKR mice compared with in controls. Western blot analysis found that MM1.S xenografts from Rag1\u2212\/\u2212\/MKR mice had higher phosphorylated S6 ribosomal protein (Ser235\/236) levels, indicating greater activation of the mammalian target of rapamycin pathway. Our study is, to\u00a0our knowledge, the first to evaluate racial differences in DM prevalence and survival in MM, as well as the effect of DM on tumor growth in mouse models. Our results suggest that DM may contribute to the higher incidence of MM in Black patients; and to improve survival in MM, DM management cannot be ignored.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023010815","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T10:00:13Z","timestamp":1695981613000},"page":"236-247","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8419-1091","authenticated-orcid":false,"given":"Urvi A.","family":"Shah","sequence":"first","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8912-4709","authenticated-orcid":false,"given":"Erin","family":"Moshier","sequence":"additional","affiliation":[{"name":"3Department of Population Health Science and Policy, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-8493","authenticated-orcid":false,"given":"Andriy","family":"Derkach","sequence":"additional","affiliation":[{"name":"4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Huang","sequence":"additional","affiliation":[{"name":"5Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sham","family":"Mailankody","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyn R.","family":"Tan","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-4854","authenticated-orcid":false,"given":"Kylee","family":"Maclachlan","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9045-6495","authenticated-orcid":false,"given":"Malin","family":"Hultcrantz","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5538-4318","authenticated-orcid":false,"given":"Neha","family":"Korde","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Hassoun","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-5136","authenticated-orcid":false,"given":"Santiago","family":"Thibaud","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larysa","family":"Sanchez","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambavi","family":"Richard","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-0585","authenticated-orcid":false,"given":"Joshua","family":"Richter","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rossi","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-5757","authenticated-orcid":false,"given":"Hearn Jay","family":"Cho","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9321-702X","authenticated-orcid":false,"given":"Alexander","family":"Lesokhin","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"2Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajai","family":"Chari","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Z.","family":"Usmani","sequence":"additional","affiliation":[{"name":"1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2934-6518","authenticated-orcid":false,"given":"Sundar","family":"Jagannath","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-8469","authenticated-orcid":false,"given":"Samir","family":"Parekh","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Gallagher","sequence":"additional","affiliation":[{"name":"7Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"2024010916285446700_bib1","volume-title":"National Diabetes Statistics Report, 2020","year":"2020"},{"key":"2024010916285446700_bib2","volume-title":"National Health and Nutrition Examination Survey 2017\u2013March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes, NHSR No. 158","year":"2021"},{"issue":"3","key":"2024010916285446700_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","article-title":"Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records","volume":"9","author":"Pearson-Stuttard","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024010916285446700_bib4","unstructured":"SEER\u2217Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute. 2023. Updated 8 June 2023. Accessed 23 October 2023. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Data source(s): SEER Incidence Data, November 2022 Submission (1975-2020), SEER 22 registries."},{"issue":"1","key":"2024010916285446700_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1022268103136","article-title":"Myeloma and race: a review of the literature","volume":"22","author":"Benjamin","year":"2003","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"2024010916285446700_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ijc.2910430404","article-title":"A\u00a0case-control study of multiple myeloma nested in the American Cancer Society prospective study","volume":"43","author":"Boffetta","year":"1989","journal-title":"Int J Cancer"},{"issue":"12","key":"2024010916285446700_bib7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/aje\/kwv290","article-title":"Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults","volume":"183","author":"Dankner","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2024010916285446700_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00125-020-05338-7","article-title":"Association between diabetes and haematological malignancies: a population-based study","volume":"64","author":"Gong","year":"2021","journal-title":"Diabetologia"},{"issue":"1","key":"2024010916285446700_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2021.278772","article-title":"Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls","volume":"107","author":"Shah","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"2024010916285446700_bib10","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.21037\/tcr.2020.03.36","article-title":"Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"12","key":"2024010916285446700_bib11","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1055-9965.EPI-06-0007","article-title":"Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer","volume":"15","author":"Chiu","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2024010916285446700_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0609.2012.01828.x","article-title":"Pre-existing diabetes mellitus in patients with multiple myeloma","volume":"89","author":"Chou","year":"2012","journal-title":"Eur J Haematol"},{"issue":"11","key":"2024010916285446700_bib13","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1080\/10428194.2021.1933474","article-title":"Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma","volume":"62","author":"Avivi","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2024010916285446700_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/bjc.2014.307","article-title":"The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"issue":"suppl 4","key":"2024010916285446700_bib15","first-page":"228S","article-title":"The worldwide obesity epidemic","volume":"9","author":"James","year":"2001","journal-title":"Obes Res"},{"issue":"15","key":"2024010916285446700_bib16","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.908001","article-title":"Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes","volume":"15","author":"Fernandez","year":"2001","journal-title":"Genes Dev"},{"issue":"9","key":"2024010916285446700_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1530\/ERC-16-0142","article-title":"EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice","volume":"23","author":"Zelenko","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2024010916285446700_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/leu.2013.344","article-title":"Inherited genetic susceptibility to multiple myeloma","volume":"28","author":"Morgan","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"2024010916285446700_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41408-020-00347-6","article-title":"Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis","volume":"10","author":"Derman","year":"2020","journal-title":"Blood Cancer J"},{"issue":"3","key":"2024010916285446700_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.1996.14.3.974","article-title":"Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229","volume":"14","author":"Modiano","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2024010916285446700_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cam4.2656","article-title":"Connect MM Registry as a national reference for United States multiple myeloma patients","volume":"9","author":"Ailawadhi","year":"2020","journal-title":"Cancer Med"},{"issue":"2","key":"2024010916285446700_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer J"},{"issue":"12","key":"2024010916285446700_bib23","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1002\/ajh.26360","article-title":"Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: a propensity-score matched analysis","volume":"96","author":"Patel","year":"2021","journal-title":"Am J Hematol"},{"issue":"4","key":"2024010916285446700_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41408-022-00665-x","article-title":"Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data","volume":"12","author":"Maignan","year":"2022","journal-title":"Blood Cancer J"},{"issue":"8","key":"2024010916285446700_bib25","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1016\/j.clml.2022.03.014","article-title":"Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: a real-world chart review study","volume":"22","author":"Atrash","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"2024010916285446700_bib26","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/bloodadvances.2021006652","article-title":"Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma","volume":"6","author":"Peres","year":"2022","journal-title":"Blood Adv"},{"issue":"24","key":"2024010916285446700_bib27","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.2019000406","article-title":"With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study","volume":"133","author":"Fillmore","year":"2019","journal-title":"Blood"},{"issue":"8","key":"2024010916285446700_bib28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer--viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024010916285446700_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41375-021-01443-7","article-title":"A\u00a0comprehensive review of the impact of obesity on plasma cell disorders","volume":"36","author":"Parikh","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"2024010916285446700_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41408-022-00782-7","article-title":"Extreme body mass index and survival in newly diagnosed multiple myeloma patients","volume":"13","author":"Shah","year":"2023","journal-title":"Blood Cancer J"},{"issue":"10","key":"2024010916285446700_bib32","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1634\/theoncologist.2013-0015","article-title":"Influence of body mass index on survival in veterans with multiple myeloma","volume":"18","author":"Beason","year":"2013","journal-title":"Oncologist"},{"issue":"9","key":"2024010916285446700_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","article-title":"The obesity paradox in cancer: a review","volume":"18","author":"Lennon","year":"2016","journal-title":"Curr Oncol Rep"},{"issue":"24","key":"2024010916285446700_bib34","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jnci\/djt310","article-title":"An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma","volume":"105","author":"Hakimi","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"2024010916285446700_bib35","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3390\/nu9111176","article-title":"The role of mammalian target of rapamycin (mTOR) in insulin signaling","volume":"9","author":"Yoon","year":"2017","journal-title":"Nutrients"},{"key":"2024010916285446700_bib36","doi-asserted-by":"crossref","first-page":"874325","DOI":"10.3389\/fonc.2022.874325","article-title":"Inhibiting PI3K-AKT-mTOR signaling in multiple myeloma-associated mesenchymal stem cells impedes the proliferation of multiple myeloma cells","volume":"12","author":"Heinemann","year":"2022","journal-title":"Front Oncol"},{"key":"2024010916285446700_bib47","doi-asserted-by":"crossref","first-page":"m3176","DOI":"10.1136\/bmj.m3176","article-title":"Emerging immunotherapies in multiple myeloma","volume":"370","author":"Shah","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"2024010916285446700_bib37","first-page":"342","article-title":"A\u00a0plant-based diet for the prevention and treatment of type 2 diabetes","volume":"14","author":"McMacken","year":"2017","journal-title":"J\u00a0Geriatr Cardiol"},{"issue":"11","key":"2024010916285446700_bib38","doi-asserted-by":"crossref","first-page":"e2025454","DOI":"10.1001\/jamanetworkopen.2020.25454","article-title":"Effect of a low-fat vegan diet on body weight, insulin sensitivity, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults: a randomized clinical trial","volume":"3","author":"Kahleova","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2024010916285446700_bib39","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3390\/nu12102917","article-title":"Effects of a low-fat vegan diet on gut microbiota in overweight individuals and relationships with body weight, body composition, and insulin sensitivity. a randomized clinical trial","volume":"12","author":"Kahleova","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"2024010916285446700_bib40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/nu10020189","article-title":"A\u00a0plant-based dietary intervention improves beta-cell function and insulin resistance in overweight adults: a 16-week randomized clinical trial","volume":"10","author":"Kahleova","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"2024010916285446700_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-020-01209-1","article-title":"Effect of a plant-based, low-fat diet versus an animal-based, ketogenic diet on ad libitum energy intake","volume":"27","author":"Hall","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"2024010916285446700_bib42","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1038\/nutd.2017.3","article-title":"The BROAD study: a randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes","volume":"7","author":"Wright","year":"2017","journal-title":"Nutr Diabetes"},{"issue":"suppl 1","key":"2024010916285446700_bib43","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1182\/blood-2022-163281","article-title":"A\u00a0pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression","volume":"140","author":"Shah","year":"2022","journal-title":"Blood"},{"issue":"5","key":"2024010916285446700_bib44","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41375-023-01874-4","article-title":"Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders","volume":"37","author":"Shah","year":"2023","journal-title":"Leukemia"},{"issue":"5","key":"2024010916285446700_bib45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1158\/0008-5472.CAN-15-2934","article-title":"Dual targeting of CDK4 and ARK5 using a novel kinase inhibitor ON123300 exerts potent anticancer activity against multiple myeloma","volume":"76","author":"Perumal","year":"2016","journal-title":"Cancer Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/1\/236\/2180505\/blooda_adv-2023-010815-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/1\/236\/2180505\/blooda_adv-2023-010815-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:29:33Z","timestamp":1704799773000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/1\/236\/498166\/Prevalence-and-impact-of-diabetes-on-survival-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010815","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}